U.S. Water Utilities Stock News

Why Flywire’s New Hospitality Partnership Matters Flywire (FLYW) has expanded its relationship with Davidson Hospitality Group, rolling out its payment and e-signature tools across more properties after Davidson reported meaningful processing fee savings and faster guest deposit and contract workflows. Recent trading shows Flywire’s 90-day share price return of 21.48% and year-to-date gain of 28.56% have been strong, while the 1-year total shareholder return of 33.86% contrasts with a 3-year...

Recent commentary on Danaher (DHR) has focused on the stock’s limited upside compared with the S&P 500, tying that underperformance to concerns around organic revenue trends, margins, and earnings per share. Over the past year Danaher has delivered a 6.1% total shareholder return, even though the share price is down 13.1% year to date and recently eased from its 90 day gain of 11.1%. This points to fading short term momentum despite a more resilient longer term picture when dividends are...

C.H. Robinson Worldwide has delivered a strong 5 year run for shareholders, yet current valuation checks suggest the stock now trades at a premium to what its intrinsic value estimate implies. The share price return of 95.7% over 5 years points to a business that investors have rewarded heavily. Management’s handling of the US$604m legal verdict and potential insurance cost pass through can influence how investors think about future cash flows and risk. The company screens as overvalued on...

Paychex (PAYX) has drawn investor attention after recent price moves and mixed short term returns. The payroll and HR services stock last closed at $115.80, with performance varying sharply between the past month and the past 3 months. Recent trading suggests momentum for Paychex is softening in the short run, with the share price down 4.9% over the past week and 3.8% over the past month. This comes even though the 3 month share price return of 15.1% and 3 year total shareholder return of...

BridgeBio Pharma (BBIO) returned to focus after fresh PROPEL 3 data on oral infigratinib in achondroplasia, with management highlighting 52 week trends in sleep apnea, ear infections, growth and body proportionality. BridgeBio Pharma’s latest PROPEL 3 update lands after a choppy stretch in the market, with the share price at US$72.44 and a 30 day share price return down 13.6%, even as the 1 year total shareholder return is up 41.46% and the 3 year total shareholder return is up 148.68%. This...

Lemonade (LMND) just broadened its footprint, rolling out renters insurance in Kentucky and Kansas, alongside Lemonade Car and an Autonomous Car pricing program for Missouri Tesla drivers. Lemonade is expanding into new states at a time when momentum in the share price has cooled, with the stock down 7.5% over the past week and 35% year to date on a share price basis, even as the three-year total shareholder return remains very large. Scan beyond Lemonade and see how other insurers are being...

Sensata Technologies recently introduced its OmniNode high voltage power distribution platform for commercial vehicles and its R290 Pressure + Temperature Sensor for electrified thermal systems, both aimed at simplifying engineering, meeting safety rules and supporting OEM adoption of new architectures and refrigerants. These launches push Sensata Technologies further into system level solutions, where combining multiple functions in one module can affect content per vehicle, customer...

Unity Software (U) is back in focus as the next earnings report approaches and Wall Street weighs projected jumps in earnings per share and revenue against weaker long term growth, softer billings and thinning margins. Recent trading has been choppy. Unity Software’s share price has climbed 61.4% over the past 90 days and the 1 year total shareholder return is 0.9%. However, the 5 year total shareholder return is still down 67.8%, which signals that momentum has picked up in the short term...

Molina Healthcare comes into focus as a stock with solid gains over the past year but a sharp decline of about 38% over three years, while its valuation checks still flag it as cheap on the broader metrics. Recent revenue pressure and customer losses have unsettled sentiment, yet the current pricing screens as undervalued on core multiples. The share price has fallen roughly 38% over three years, which suggests longer term holders have absorbed a heavy drawdown that is not fully reflected in...

Denali Therapeutics has delivered a strong 1 year rebound for shareholders, yet multiple valuation checks suggest the current share price sits above where an intrinsic value estimate and market based comparisons would place it. The stock therefore looks priced for meaningful execution on its drug pipeline even after a difficult 5 year stretch. Over 5 years, Denali Therapeutics shareholders have seen the investment fall about 60%, which hints that earlier optimism has not yet translated into...

Carlyle Group (CG) is back in focus after portfolio company Exiger rolled out its AI native 1Exiger platform, following a US$1.2b investment round that involved Carlyle and other backers. Despite Exiger’s AI push grabbing headlines, Carlyle Group’s recent share price performance has been weak. The stock is down 12.29% over 30 days and 30.43% year to date, while a 3-year total shareholder return of 38.05% shows a more constructive longer-term record. Scan other private markets and AI exposed...

Clorox (CLX) has come under pressure recently, with the share price down 17% over the past month and 9% in the past 3 months. This has put the consumer staples group back under the microscope for investors. Zooming out, Clorox’s 1-year total shareholder return is down 25.63%, and the 3-year and 5-year total shareholder returns are also lower. This suggests that recent weakness in the share price is part of a longer period of fading momentum around the stock. Compare Clorox’s recent slide with...

Fastly stock has almost tripled over the past year, yet the broader valuation checks suggest the current share price leans expensive rather than offering clear value. The 199.6% return over the past 12 months highlights how quickly expectations around Fastly have shifted and raises the bar for what needs to go right next. Expectations for continued adoption of Fastly's edge computing and content delivery services can support a higher valuation. However, any setback in turning that usage into...

Artisan Partners Asset Management stock has fallen over recent months, yet several valuation checks suggest the shares may be pricing in more caution than the business fundamentals imply. After a three year gain of 30.7%, the recent pullback leaves investors weighing a cheaper entry point against the usual uncertainties around future fee income and fund flows. Over the past 3 years, Artisan Partners Asset Management has returned 30.7%, which points to meaningfully positive longer term...

Southwest Airlines (LUV) has drawn investor attention after recent share price weakness, with the stock down about 13% over the past month and roughly 14% over the past 3 months. The recent 12.8% 1 month and 13.7% 3 month share price declines suggest momentum for Southwest Airlines is fading in the short term, even though the 1 year total shareholder return of 26.2% and 3 year total shareholder return of 40.9% still point to a stronger longer run record. Scan for other airline and travel...

Fortune Brands Innovations (NYSE:FBIN) appointed Peter G. Clifford as Chief Financial Officer and Executive Vice President, effective September 21, 2026. Clifford brings more than 30 years of finance and operational leadership across building products and healthcare businesses. His background includes experience in finance transformation, global operations and M&A activity at publicly traded companies. The appointment of Peter G. Clifford as CFO and Executive Vice President is important...

10x Genomics has delivered a very strong 1 year gain while the broader valuation checks still flag the stock as expensive rather than a clear bargain. The share price return over the past 12 months is 442.6%, which puts 10x Genomics among the more extreme recent movers in the market and raises the bar for what needs to go right next. The newly announced collaboration with Lunit on AI enabled pathology analysis can support optimism around long term demand, while execution risk in scaling the...

Pinterest has reported that it now serves more than 640 million users and is positioning itself as an AI-driven shopping assistant, with over two thirds of revenue tied to lower funnel performance advertising and around 30% of that processed through its Performance+ platform. The acquisition of tvScientific moves Pinterest into connected TV advertising, which broadens monetization channels while the group still contends with European regulation and a reworked international sales...

Applied Materials stock has delivered very strong gains over the last three years, yet the current valuation picture sends mixed signals. Investors see a powerful multiyear return profile set against a broader checkup that does not clearly label the shares as either cheap or stretched. For anyone looking at Applied Materials today, the key question is whether the recent pullback meaningfully improves the entry point or simply trims some heat off a still fully valued story. Over the last 3...

Workiva has seen its share price fall over the longer term, yet the stock still screens as relatively expensive on market multiples. This leaves investors weighing whether the current level fairly reflects its prospects. With a mixed value score and a long stretch of negative returns, the question is how much optimism is already baked into Workiva’s valuation today. Workiva shares have declined 53.4% over 5 years, which suggests long term holders have absorbed significant capital pressure...

Oshkosh stock has delivered a 56.1% gain over the past three years, yet current valuation checks suggest the shares still trade at a discount to what the underlying cash flows imply. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside compared with the recent US$145.85 close, and market multiple checks tell a similar story. A 56.1% return over three years points to a business that has rewarded patient holders, while the latest move still leaves room for...

Matson stock reaction puts recent gains under the microscope Fresh research attention on Matson (MATX), including a top Zacks Rank and strong broker sentiment, has pushed the stock further into the spotlight after a solid multi month price run. At a share price of $230.18, Matson has seen strong short term momentum, with a 30 day share price return of 7.33% and a year to date share price return of 86.06%. The 1 year total shareholder return of 124.82% highlights how powerful this move has...

United Bankshares has delivered strong share price gains over the past few years, yet the valuation checks send a mixed message, with an Excess Returns intrinsic value estimate pointing to upside while earnings based multiples lean the other way. For investors, the puzzle is whether the current US$47.22 price still leaves enough breathing room if expectations cool. Over the past 3 years, United Bankshares has returned about 88.9%, which puts extra focus on whether the current level already...

NRG Energy has delivered a powerful run over the past five years, yet the stock is now coming off a sharp pullback and the broader valuation checks suggest pricing that looks neither clearly cheap nor clearly expensive. NRG Energy has returned about 207.5% over five years, which puts long term holders in a strong position even though more recent returns have cooled. The business can see its valuation influenced by how reliably it converts cash from its power portfolio, while any hit to cash...